These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2444843)
1. Screening for Down syndrome. Lancet; 1987 Nov; 2(8567):1083-4. PubMed ID: 2444843 [No Abstract] [Full Text] [Related]
2. Screening for Down's syndrome. N Engl J Med; 1988 Apr; 318(14):926-9. PubMed ID: 2451130 [No Abstract] [Full Text] [Related]
3. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852 [TBL] [Abstract][Full Text] [Related]
4. Triple-marker screening of serum for Down's syndrome. Herrmann J N Engl J Med; 1994 Sep; 331(10):681-2. PubMed ID: 7519744 [No Abstract] [Full Text] [Related]
6. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome]. Bessho T; Kanazawa R; Shiotani T; Mitsuo M; Koyama K Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):237-43. PubMed ID: 7535328 [TBL] [Abstract][Full Text] [Related]
7. Current techniques of prenatal screening for Down syndrome. Cardwell MS; Gay JW Mo Med; 1990 May; 87(5):295-7. PubMed ID: 1694954 [TBL] [Abstract][Full Text] [Related]
8. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers]. Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254 [TBL] [Abstract][Full Text] [Related]
13. Amniocentesis. The experience in a district hospital. Ogueh O; Baffour M; Hibbert K; McMillan L Clin Exp Obstet Gynecol; 1996; 23(3):133-5. PubMed ID: 8894318 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome. Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896 [TBL] [Abstract][Full Text] [Related]
15. A 35-year-old pregnant woman considering maternal serum screening and amniocentesis, 1 year later. Daley J; Delbanco TL; Hartman EE JAMA; 1996 Dec; 276(22):1840. PubMed ID: 8946906 [No Abstract] [Full Text] [Related]
16. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [TBL] [Abstract][Full Text] [Related]
17. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909 [TBL] [Abstract][Full Text] [Related]
18. [Antenatal screening for Down syndrome: a smattering of epidemiology]. Boulvain M; Billieux MH; Irion O Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178 [TBL] [Abstract][Full Text] [Related]
19. Biochemical screening tests for Down syndrome. Coetzee E; Viljoen D S Afr Med J; 1995 Feb; 85(2):72-3. PubMed ID: 7541163 [No Abstract] [Full Text] [Related]
20. Maternal alpha-fetoprotein screening for Down's syndrome. Pueschel SM N Engl J Med; 1987 Aug; 317(6):376-8. PubMed ID: 2439910 [No Abstract] [Full Text] [Related] [Next] [New Search]